Meijer F, Ruijter J M, Van Delft J L, Van Haeringen N J
Biochemical Laboratory, The Netherlands Ophthalmic Research Institute, Amsterdam, Netherlands.
Eur J Pharmacol. 1995 Sep 15;284(1-2):61-7. doi: 10.1016/0014-2999(95)00376-v.
The role of nitric oxide (NO) as an inflammatory mediator in the mechanism of increased microvascular permeability was examined in a guinea pig model of allergic conjunctivitis. Topical challenge with antigen, compound 48/80, histamine or platelet activating factor (PAF) resulted in a marked increase of the conjunctival vascular permeability. Vascular permeability was determined by measuring the albumin content in the lavage fluid of the challenged eyes after 30 min. Pretreatment with NG-nitro-L-arginine methyl ester (L-NAME) eyedrops caused a significant inhibition of the clinical score and the vascular permeability after challenge with either antigen, histamine or PAF. Aminoguanidine prophylaxis also resulted in a significant inhibition of both the clinical score and vascular permeability in response to all the used provocative agents except PAF. Our observations indicate that NO is an important factor in the induction of the vascular permeability provoked by histamine but seems to play no role in the mechanism by which PAF exerts increased vascular permeability in the conjunctiva.
在豚鼠过敏性结膜炎模型中,研究了一氧化氮(NO)作为炎症介质在微血管通透性增加机制中的作用。用抗原、化合物48/80、组胺或血小板活化因子(PAF)进行局部激发,导致结膜血管通透性显著增加。通过测量激发后30分钟受激眼灌洗液中的白蛋白含量来测定血管通透性。用NG-硝基-L-精氨酸甲酯(L-NAME)滴眼液预处理,在用抗原、组胺或PAF激发后,可显著抑制临床评分和血管通透性。氨基胍预防也导致对所有所用激发剂(PAF除外)的临床评分和血管通透性均有显著抑制。我们的观察结果表明,NO是组胺诱导血管通透性的重要因素,但似乎在PAF使结膜血管通透性增加的机制中不起作用。